annual accounts payable:
$11.14M+$1.65M(+17.44%)Summary
- As of today (June 17, 2025), DNLI annual accounts payable is $11.14 million, with the most recent change of +$1.65 million (+17.44%) on December 31, 2024.
- During the last 3 years, DNLI annual accounts payable has risen by +$6.36 million (+133.04%).
- DNLI annual accounts payable is now at all-time high.
Performance
DNLI Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$8.46M-$2.68M(-24.05%)Summary
- As of today (June 17, 2025), DNLI quarterly accounts payable is $8.46 million, with the most recent change of -$2.68 million (-24.05%) on March 31, 2025.
- Over the past year, DNLI quarterly accounts payable has dropped by -$3.40 million (-28.65%).
- DNLI quarterly accounts payable is now -39.31% below its all-time high of $13.94 million, reached on June 30, 2024.
Performance
DNLI quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DNLI Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.4% | -28.6% |
| 3 y3 years | +133.0% | +151.9% |
| 5 y5 years | +330.0% | +265.2% |
DNLI Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +299.2% | -39.3% | +615.6% |
| 5 y | 5-year | at high | +939.9% | -39.3% | +689.7% |
| alltime | all time | at high | +939.9% | -39.3% | +689.7% |
DNLI Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $8.46M(-24.1%) |
| Dec 2024 | $11.14M(+17.4%) | $11.14M(+16.1%) |
| Sep 2024 | - | $9.59M(-31.2%) |
| Jun 2024 | - | $13.94M(+17.6%) |
| Mar 2024 | - | $11.86M(+25.0%) |
| Dec 2023 | $9.48M(+239.9%) | $9.48M(+702.3%) |
| Sep 2023 | - | $1.18M(-86.1%) |
| Jun 2023 | - | $8.52M(+284.7%) |
| Mar 2023 | - | $2.21M(-20.6%) |
| Dec 2022 | $2.79M(-41.6%) | $2.79M(-63.0%) |
| Sep 2022 | - | $7.54M(+5.9%) |
| Jun 2022 | - | $7.12M(+111.9%) |
| Mar 2022 | - | $3.36M(-29.7%) |
| Dec 2021 | $4.78M | $4.78M(-0.8%) |
| Sep 2021 | - | $4.82M(+13.7%) |
| Jun 2021 | - | $4.24M(+160.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $1.63M(+51.8%) |
| Dec 2020 | $1.07M(-58.6%) | $1.07M(-61.8%) |
| Sep 2020 | - | $2.81M(+50.4%) |
| Jun 2020 | - | $1.87M(-19.4%) |
| Mar 2020 | - | $2.32M(-10.6%) |
| Dec 2019 | $2.59M(+37.0%) | $2.59M(+28.1%) |
| Sep 2019 | - | $2.02M(-48.6%) |
| Jun 2019 | - | $3.93M(+7.3%) |
| Mar 2019 | - | $3.66M(+93.7%) |
| Dec 2018 | $1.89M(-30.4%) | $1.89M(-43.6%) |
| Sep 2018 | - | $3.35M(-63.4%) |
| Jun 2018 | - | $9.18M(+566.4%) |
| Mar 2018 | - | $1.38M(-49.3%) |
| Dec 2017 | $2.72M(+38.4%) | $2.72M(+19.6%) |
| Sep 2017 | - | $2.27M(+15.6%) |
| Dec 2016 | $1.96M(+14.6%) | $1.96M |
| Dec 2015 | $1.71M | - |
FAQ
- What is Denali Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Denali Therapeutics?
- What is Denali Therapeutics annual accounts payable year-on-year change?
- What is Denali Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Denali Therapeutics?
- What is Denali Therapeutics quarterly accounts payable year-on-year change?
What is Denali Therapeutics annual accounts payable?
The current annual accounts payable of DNLI is $11.14M
What is the all time high annual accounts payable for Denali Therapeutics?
Denali Therapeutics all-time high annual accounts payable is $11.14M
What is Denali Therapeutics annual accounts payable year-on-year change?
Over the past year, DNLI annual accounts payable has changed by +$1.65M (+17.44%)
What is Denali Therapeutics quarterly accounts payable?
The current quarterly accounts payable of DNLI is $8.46M
What is the all time high quarterly accounts payable for Denali Therapeutics?
Denali Therapeutics all-time high quarterly accounts payable is $13.94M
What is Denali Therapeutics quarterly accounts payable year-on-year change?
Over the past year, DNLI quarterly accounts payable has changed by -$3.40M (-28.65%)